Catherine Beauchemin

BSc UofOttawa, PhD UofAlberta
Associate Professor

Profile picture - Catherine Beauchemin
KHS 331
350 Victoria St. Toronto, ON M5B 2K3
t. 416-979-5000 x2508
f. 416-979-5343
cbeau@ryerson.ca

Specialization

Computational/mathematical modelling of self-organizing systems. Modelling dynamics of infectious diseases within a host and host/immune interactions.

Research Projects

The phymbie research group has many ongoing projects. Visit the phymbie website for more details about projects and opened positions.

Selected Publications

  • Iwami, S, BP Holder, CAA Beauchemin, S Morita, T Tada, K Sato, T Igarashi, and T Miura. Quantification system for the viral dynamics of a highly pathogenic simian/human immunodeficiency virus based on an in vitro experiment and a mathematical model. Retrovirology, 9(1):18, 2012. doi:10.1186/1742-4690-9-18

  • Beauchemin, CAA. Agent-Based Models in Infectious Disease and Immunology. Entry in Björn Engquist, editor, Encyclopedia of Applied and Computational Mathematics, Springer-Verlag, Germany, Dec 2012.
    [Online: Publisher's website]

  • Holder, BP, LE Liao, P Simon, G Boivin, and CAA Beauchemin. Design considerations in building in silico equivalents of common experimental influenza virus assays and the benefits of such an approach. Autoimmunity, 44(4), 2011. doi:10.3109/08916934.2011.523267

  • Holder, BP, P Simon, LE Liao, Y Abed, X Bouhy, CAA Beauchemin, and G Boivin. Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model. PLoS ONE, 6(3):e14767, 2011. doi:10.1371/journal.pone.0014767

  • Simon, P, BP Holder, X Bouhy, Y Abed, CAA Beauchemin, and G Boivin. The I222V neuraminidase mutation has a compensatory role in the replication of an oseltamivir-resistant A/H3N2 E119V mutant. J. Clin. Microbiol., 49(2):715-717, 2011. doi:10.1128/JCM.01732-10

  • Holder, BP, and CAA Beauchemin. Exploring the effect of implementing different biological delays in constructing kinetic models of influenza infection within a host or cell culture. BMC Public Health, 11(Suppl 1):S10, 2011. doi:10.1186/1471-2458-11-S1-S10

  • Beauchemin, CAA, and A Handel. A review of mathematical models of influenza A infections within a host or cell culture: Lessons learned and challenges ahead. BMC Public Health, 11(Suppl 1):S7, 2011. doi:10.1186/1471-2458-11-S1-S7

  • Dobrovolny, HM, R Gieschke, BE Davies, NL Jumbe, and CAA Beauchemin. Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study. J. Theor. Biol., 269(1):234-244, 2011. doi:10.1016/j.jtbi.2010.10.017

  • Mitchell, H, D Levin, S Forrest, CAA Beauchemin, J Tipper, J Knight, N Donart, RC Layton, J Pyles, P Gao, KS Harrod, AS Perelson, and F Koster. Higher replication efficiency of 2009 (H1N1) pandemic influenza than seasonal and avian strains: Kinetics from epithelial cell culture and computational modeling. J. Virol., 85(2):1125-1135, 2011. doi:10.1128/JVI.01722-10

  • Dobrovolny, HM, MJ Baron, R Gieschke, BE Davies, NL Jumbe, and CAA Beauchemin. Exploring cell tropism as a possible contributor to influenza infection severity. PLoS ONE, 5(11):e13811, 2010. doi:10.1371/journal.pone.0013811

Funding

  • NSERC Discovery Grant
  • CIHR Operating Grant (PI: Guy Boivin)

Website

http://phymbie.physics.ryerson.ca

Group

phymbie

Group Members

See the phymbie research team page.

Research Collaborators

Guy Boivin, Centre Hospitalier de l'Université Laval

Thesis Links

See the theses of the phymbie group members next to their profile on the phymbie research team page.


History

Member for
1 year 6 weeks
Blog